Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

220
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

271
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
271
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

376
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
376
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

893
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
893
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

219
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
219

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Impact of hemoglobin glycation index and stress hyperglycemia ratio on short-term mortality in critically ill patients with heart failure: a retrospective cohort study using the MIMIC database.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026
Same author

Targeting skin barrier repair: mechanisms of action, therapeutic evidence, and clinical translation challenges of mesenchymal stem cell-derived exosomes.

Stem cell research & therapy·2026
Same author

Intense pulsed light rejuvenates UVB-induced photoaging in human keratinocytes and guinea pig skin by inhibition of ERK-AP-1-MMP pathway.

Scientific reports·2026
Same author

Optoacoustic muscle imaging.

Journal of neuromuscular diseases·2026
Same author

Mapping lung function in late-onset Pompe disease using label-free functional MRI.

iScience·2026
Same author

Altered brain network topology in adolescents with major depressive disorder and bipolar disorder: A resting-state fMRI graph-theoretical and machine learning study.

Journal of affective disorders·2026

相关实验视频

Updated: Jan 18, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

4.2K

冠状动脉微血管功能障碍的跨冠状动脉鼻腔疗法

Jingjing Rao1, Yue Wang1, Lina Tan1

  • 1Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, 530021 Nanning, Guangxi, China.

Reviews in cardiovascular medicine
|September 10, 2025
PubMed
概括
此摘要是机器生成的。

冠状动脉微血管疾病影响心血管事件和治疗结果. 冠状动脉鼻干预对耐火性心痛有希望,但最近的试验在减少心脏病发作大小方面产生了不同的结果.

关键词:
ST段升高心肌梗塞的心脏病发作胸痛是一种心痛.冠状动脉微循环障碍 冠状动脉微循环障碍冠状动脉鼻减小剂 冠状动脉鼻减小剂压力控制的间歇性冠状动脉鼻闭塞.

更多相关视频

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

8.4K
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.8K

相关实验视频

Last Updated: Jan 18, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

4.2K
Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

8.4K
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.8K

科学领域:

  • 心脏病学 心脏病学
  • 血管医学 血管医学
  • 干预心脏病学 干预心脏病学

背景情况:

  • 冠状动脉微血管疾病 (CMD) 与心血管事件的增加和重血管化后的较差结果有关.
  • 慢性心脏病常常与上心脏病共存,导致运动耐受性和症状降低,尽管治疗最佳.
  • 在重血管化后管理微血管阻塞仍然是一个重大的临床挑战.

研究的目的:

  • 对冠状动脉微血管疾病的冠状动脉鼻腔治疗方法的最新进展进行审查.
  • 评估冠状动脉鼻干预措施在管理CMD方面的有效性和挑战.
  • 讨论冠状动脉系统在治疗微血管阻塞方面的潜力.

主要方法:

  • 关于冠状动脉鼻干预CMD的当前文献的综述.
  • 对冠状动脉缩剂和压力控制间歇性冠状动脉封闭的数据分析.
  • 检查最近的随机试验结果,比较干预措施.

主要成果:

  • 冠状动脉鼻干预可能对70-80%的耐火性心痛和CMD患者有益,这些患者不符合再血管化的条件.
  • 这些干预措施调节冠状动脉压力,提供临床帮助.
  • 最近的一项试验显示,与传统的PCI相比,在压力控制的间歇性冠状动脉鼻封闭时,心脏病发作大小的减少没有显著差异.

结论:

  • 冠状动脉鼻干预是CMD管理的新方法.
  • 虽然对耐火性心痛有希望,但需要进一步的研究来澄清疗效,特别是关于心脏病发作大小的减少.
  • 冠状动脉系统为复杂的冠状动脉微血管阻塞提供了潜在的治疗途径.